Credential Qtrade Securities’s Takeda Pharmaceutical TAK Stock Holding History

Credential Qtrade Securities’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-45,760	Closed	-$750K	–	391
2021 Q3	$750K	Buy	45,760 +6,560	+17%	+$110K	0.06%	147
2021 Q2	$660K	Buy	39,200 +11,620	+42%	+$198K	0.05%	157
2021 Q1	$504K	Buy	+27,580	New	+$496K	0.05%	158
2020 Q2	–	Sell	-60	Closed	-$910	–	311
2020 Q1	$910	Hold	60	–	–	﹤0.01%	288
2019 Q4	$1.18K	Hold	60	–	–	﹤0.01%	301
2019 Q3	$1.03K	Hold	60	–	–	﹤0.01%	272
2019 Q2	$1.06K	Sell	60 -201	-77%	-$3.66K	﹤0.01%	293
2019 Q1	$5.32K	Buy	+261	New	+$5.25K	﹤0.01%	254

Other funds holding TAK

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BCP

BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credential Qtrade Securities's TAK Position: Q4 2021 in Review

Credential Qtrade Securities sold out of Takeda Pharmaceutical (TAK) in Q4 2021, closing a stake of 45,760 shares — an estimated $750K sold.

Credential Qtrade Securities first reported a position in TAK in Q1 2019 and held it in 8 quarters. The position peaked at $750K in Q3 2021. 298 funds tracked by Wall St. Rank hold TAK as of Q4 2021.

Credential Qtrade Securities reported no remaining Takeda Pharmaceutical position as of Q4 2021 after selling out during the quarter.
Credential Qtrade Securities sold 45,760 Takeda Pharmaceutical shares in Q4 2021, an estimated $750K.
Credential Qtrade Securities first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 8 quarters.
Credential Qtrade Securities's Takeda Pharmaceutical position peaked at $750K in Q3 2021.
298 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2021.

Based on Credential Qtrade Securities's 13F filing for Q4 2021, filed 21 Jul 2025.